Top Cannabis Stocks Emerging as Diamonds in the Rough
Wed November 20, 2019
Houston, Texas--(Newsfile Corp. - November 20, 2019) - MarijuanaStox announces publication of an article that discusses The Yield Growth Corporation (CSE: BOSS)(OTCQB: BOSQF). The company has been aggressively addressing demand for health, wellness, and beauty products infused with premium-cannabis and hemp-based products on an international scale with subsidiary, Urban Juve.
Long-Term Cannabis Investors Should Ignore the Noise
There's plenty of noise impacting cannabis stocks at the moment.
Poor earnings from some of the industry's top names have wreaked havoc. The rollout of legal cannabis in Canada hasn't produced the rewards many were looking for. Some companies are facing a severe cash crunch. Former Vice President Joe Biden just said he won't support cannabis legalization because he believes it's a gateway drug. Related stocks even slid on the vaping controversy with a nationwide crackdown.
Cannabis producers are burning through cash to expand. Sales growth has so far been disappointing investors with sky-high expectations. Under- and oversupply issues have hurt businesses followed by layoffs and regulatory issues.
However, that's all short-term noise.
We have to consider the downed market still offers plenty of long-term opportunity.
Remember, the Marijuana Business Factbook estimates the industry could be worth $77 billion by 2022. The Brightfield Group says worldwide CBD sales are expected to soar from $591million in 2018 to as high as $22 billion by 2022.
Analysts at Arcview Market Research and BDS Analytics foresee worldwide sales surpassing $55 billion by 2024. Even Piper Jaffray says the market could be worth up to $100 billion.
And while estimates vary, one thing is very clear.
Growth is expected to be incredibly explosive. All thanks to incredible demand from consumers.
In the U.S. alone, a Gallup survey found that 66% of Americans are in favor of legalization. That's up from just 60% in 2016. A Pew survey found that 62% of Americans want to see cannabis legalization in the country, as compared to just 57% in 2015.
Sure, not all cannabis companies will survive the recent downturn. However, there are a handful of companies that have become diamonds in the rough.
The Yield Growth Corporation is One of the Major Beneficiaries
It's been quite a year for The Yield Growth Corporation.
While other companies have struggled, Yield Growth has produced consistent revenue growth over six consecutive quarters. In its third quarter of 2019, revenue increased 61% to $1.9 million in Q3 2019 compared to $1.2 million in Q2 2019, and increased by 355% compared to $0.4 million in Q3 2018. Net losses decreased by 55% to $1.9 million in Q3 2019 compared to $4.1 million in Q2 2019, and decreased by 50% compared to $3.7 million in Q3 2018.
The company also made considerable progress in building its assets, positioning itself for future growth. Total assets increased by 149% to $6.5 million from $2.6 million at 2018 year-end. Net assets increased by 250% to $4.7 million from $1.3 million at 2018 year-end. Working capital increased by 91% to $3.4 million from $1.8 million at 2018 year-end.
International growth has been just as explosive.
At the moment, the company is building a retail distribution network around the world. The company signed agreements with Melorganics, which will act as the exclusive retail distributor and non-exclusive e-commerce distributor for Urban Juve products in Greece and Cyprus, Romania, Bulgaria and Serbia, . In addition, Yield Growth signed a consumer marketing and sales alliance with ipsy, one of the world's largest beauty subscription communities.
It partnered with Peak Performance Products Inc., which will act as the wholesale distributor for Yield's Urban Juve hemp products within the health retail channel across Canada. The agreement grants Peak Performance rights to distribute and sell Urban Juve products at wholesale to health retailers across Canada.
It signed a non-binding letter of intent to enter into a co-packing agreement with Apothecary Botanicals, a Canadian licensed cannabis producer and subsidiary of Geyser Brands Inc., for the production and launch of Yield Growth's Canadian Cannabis brand Jack n Jane, a line of cannabis-infused products including tinctures, topicals and capsules.
Yield Growth also attained Oregon Liquor Control Commission (OLCC) final approval for packaging for Wright & Well products, so the products may be sold through cannabis retailers in Oregon of the United States. In addition, it obtained Compliance Certificates for registration in the European Union for its full line of Urban Juve products, allowing its products to be sold and distributed in the European market, in addition to Canada and US. Urban Juve has also signed an exclusive distribution agreement for Columbia and Brazil and is in the process of registering the products in South America.
However, it's not all about cannabis with Yield Growth.
Yield Growth Expands to Psilocybin Mushroom Market
Johns Hopkins Medicine and New York University just began uncovering the benefits of psilocybin mushrooms. In addition, according to a study featured in a 2016 issue of Science Direct, as highlighted by GOOD Magazine, psilocybin mushrooms are effective at treating treatment-resistant depression.
Findings also highlighted the drug as an effective way to treat tobacco and alcohol addiction, as well. "People who used psychedelics have lower rates of psychological distress and suicidality than those who used no psychedelics."
That's opening sizable opportunity for Yield Growth, as well.
So far, Yield Growth entered into a definitive agreement with Eurolife Brands (CANVF) for the exclusive distribution of Yield Growth's line of mushroom infused coffee mixes being developed through subsidiary Flourish Mushroom Labs Inc. The distribution agreement grants Eurolife Brands exclusive distribution rights in Germany, the United Kingdom and Switzerland for the mushroom coffee line being developed by Yield Growth subsidiary Flourish Mushroom Labs.
"We are excited about the potential for therapeutic use of legal edible mushrooms and intend to launch our coffee products in Canada and the U.S. in 2020 ," says Penny White, Yield Growth CEO. "We are also researching the legality of developing products or conducting trials on products that contain psilocin or psilocybin from magic mushrooms for potential medical use."
For more information, visit the company's website at https://yieldgrowth.com
https://seekingalpha.com/pr/17705915-top-cann...onds-rough
Wed November 20, 2019
Houston, Texas--(Newsfile Corp. - November 20, 2019) - MarijuanaStox announces publication of an article that discusses The Yield Growth Corporation (CSE: BOSS)(OTCQB: BOSQF). The company has been aggressively addressing demand for health, wellness, and beauty products infused with premium-cannabis and hemp-based products on an international scale with subsidiary, Urban Juve.
Long-Term Cannabis Investors Should Ignore the Noise
There's plenty of noise impacting cannabis stocks at the moment.
Poor earnings from some of the industry's top names have wreaked havoc. The rollout of legal cannabis in Canada hasn't produced the rewards many were looking for. Some companies are facing a severe cash crunch. Former Vice President Joe Biden just said he won't support cannabis legalization because he believes it's a gateway drug. Related stocks even slid on the vaping controversy with a nationwide crackdown.
Cannabis producers are burning through cash to expand. Sales growth has so far been disappointing investors with sky-high expectations. Under- and oversupply issues have hurt businesses followed by layoffs and regulatory issues.
However, that's all short-term noise.
We have to consider the downed market still offers plenty of long-term opportunity.
Remember, the Marijuana Business Factbook estimates the industry could be worth $77 billion by 2022. The Brightfield Group says worldwide CBD sales are expected to soar from $591million in 2018 to as high as $22 billion by 2022.
Analysts at Arcview Market Research and BDS Analytics foresee worldwide sales surpassing $55 billion by 2024. Even Piper Jaffray says the market could be worth up to $100 billion.
And while estimates vary, one thing is very clear.
Growth is expected to be incredibly explosive. All thanks to incredible demand from consumers.
In the U.S. alone, a Gallup survey found that 66% of Americans are in favor of legalization. That's up from just 60% in 2016. A Pew survey found that 62% of Americans want to see cannabis legalization in the country, as compared to just 57% in 2015.
Sure, not all cannabis companies will survive the recent downturn. However, there are a handful of companies that have become diamonds in the rough.
The Yield Growth Corporation is One of the Major Beneficiaries
It's been quite a year for The Yield Growth Corporation.
While other companies have struggled, Yield Growth has produced consistent revenue growth over six consecutive quarters. In its third quarter of 2019, revenue increased 61% to $1.9 million in Q3 2019 compared to $1.2 million in Q2 2019, and increased by 355% compared to $0.4 million in Q3 2018. Net losses decreased by 55% to $1.9 million in Q3 2019 compared to $4.1 million in Q2 2019, and decreased by 50% compared to $3.7 million in Q3 2018.
The company also made considerable progress in building its assets, positioning itself for future growth. Total assets increased by 149% to $6.5 million from $2.6 million at 2018 year-end. Net assets increased by 250% to $4.7 million from $1.3 million at 2018 year-end. Working capital increased by 91% to $3.4 million from $1.8 million at 2018 year-end.
International growth has been just as explosive.
At the moment, the company is building a retail distribution network around the world. The company signed agreements with Melorganics, which will act as the exclusive retail distributor and non-exclusive e-commerce distributor for Urban Juve products in Greece and Cyprus, Romania, Bulgaria and Serbia, . In addition, Yield Growth signed a consumer marketing and sales alliance with ipsy, one of the world's largest beauty subscription communities.
It partnered with Peak Performance Products Inc., which will act as the wholesale distributor for Yield's Urban Juve hemp products within the health retail channel across Canada. The agreement grants Peak Performance rights to distribute and sell Urban Juve products at wholesale to health retailers across Canada.
It signed a non-binding letter of intent to enter into a co-packing agreement with Apothecary Botanicals, a Canadian licensed cannabis producer and subsidiary of Geyser Brands Inc., for the production and launch of Yield Growth's Canadian Cannabis brand Jack n Jane, a line of cannabis-infused products including tinctures, topicals and capsules.
Yield Growth also attained Oregon Liquor Control Commission (OLCC) final approval for packaging for Wright & Well products, so the products may be sold through cannabis retailers in Oregon of the United States. In addition, it obtained Compliance Certificates for registration in the European Union for its full line of Urban Juve products, allowing its products to be sold and distributed in the European market, in addition to Canada and US. Urban Juve has also signed an exclusive distribution agreement for Columbia and Brazil and is in the process of registering the products in South America.
However, it's not all about cannabis with Yield Growth.
Yield Growth Expands to Psilocybin Mushroom Market
Johns Hopkins Medicine and New York University just began uncovering the benefits of psilocybin mushrooms. In addition, according to a study featured in a 2016 issue of Science Direct, as highlighted by GOOD Magazine, psilocybin mushrooms are effective at treating treatment-resistant depression.
Findings also highlighted the drug as an effective way to treat tobacco and alcohol addiction, as well. "People who used psychedelics have lower rates of psychological distress and suicidality than those who used no psychedelics."
That's opening sizable opportunity for Yield Growth, as well.
So far, Yield Growth entered into a definitive agreement with Eurolife Brands (CANVF) for the exclusive distribution of Yield Growth's line of mushroom infused coffee mixes being developed through subsidiary Flourish Mushroom Labs Inc. The distribution agreement grants Eurolife Brands exclusive distribution rights in Germany, the United Kingdom and Switzerland for the mushroom coffee line being developed by Yield Growth subsidiary Flourish Mushroom Labs.
"We are excited about the potential for therapeutic use of legal edible mushrooms and intend to launch our coffee products in Canada and the U.S. in 2020 ," says Penny White, Yield Growth CEO. "We are also researching the legality of developing products or conducting trials on products that contain psilocin or psilocybin from magic mushrooms for potential medical use."
For more information, visit the company's website at https://yieldgrowth.com
https://seekingalpha.com/pr/17705915-top-cann...onds-rough
